eslicarbazepine acetate has been researched along with Ataxia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Delanty, N; Holtkamp, M; McMurray, R; Sales, F; Serratosa, J; Villanueva, V | 1 |
| Fadda, V; Giovannelli, F; Maratea, D; Verrotti, A; Zaccara, G | 1 |
1 review(s) available for eslicarbazepine acetate and Ataxia
| Article | Year |
|---|---|
Neurological adverse events of new generation sodium blocker antiepileptic drugs. Meta-analysis of randomized, double-blinded studies with eslicarbazepine acetate, lacosamide and oxcarbazepine.
Topics: Acetamides; Anticonvulsants; Ataxia; Carbamazepine; Dibenzazepines; Diplopia; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Lacosamide; Nervous System Diseases; Oxcarbazepine; Randomized Controlled Trials as Topic; Risk Assessment; Sodium Channel Blockers; Treatment Outcome | 2013 |
1 other study(ies) available for eslicarbazepine acetate and Ataxia
| Article | Year |
|---|---|
Eslicarbazepine acetate as monotherapy in clinical practice: Outcomes from Euro-Esli.
Topics: Adult; Anticonvulsants; Ataxia; Dibenzazepines; Dizziness; Europe; Fatigue; Female; Humans; Male; Middle Aged; Seizures; Sleepiness; Vertigo | 2019 |